(Received for publication, August 12, 1996, and in revised form, October 23, 1996)
From the Department of Biochemistry of Lipids, Centre for Biomembranes and Lipid Enzymology, Institute for Biomembranes, Padualaan 8, 3584 CH Utrecht, The Netherlands
Peroxisomes are indispensable organelles for
ether lipid biosynthesis in mammalian tissues, and the deficiency of
these organelles in a number of peroxisomal disorders leads to
deficiencies in ether phospholipids. We have previously purified the
committed enzyme for ether lipid biosynthesis, i.e.
alkyl-dihydroxyacetonephosphate synthase, to homogeneity. We have now
determined the N-terminal amino acid sequence, as well as additional
internal sequences obtained after cyanogen bromide cleavage of the
enzyme. With primers directed against the N-terminal sequence and
against a cyanogen bromide fragment sequence, a 1100-bp cDNA
fragment was obtained by conventional polymerase chain reaction using
first-strand cDNA from guinea pig liver as a template. The 5 and
3
ends of the cDNA were obtained by rapid amplification of
cDNA ends. The open reading frame encodes a protein of 658 amino
acids, containing the N-terminal amino acid sequence as well as the
cyanogen bromide cleavage fragment sequences. The derived amino acid
sequence includes a mature protein 600 amino acids long and a
presequence 58 amino acids long. The latter contains a stretch of amino
acids known as peroxisomal targeting signal 2. The size of the mRNA
was estimated to be around 4200 nucleotides. Recombinant His-tagged
alkyl-dihydroxyacetonephosphate synthase expressed in Escherichia
coli was enzymatically active.
Ether phospholipids constitute a special class of natural phospholipids. In mammals, these have either an alkyl or an alkenyl ether linkage at the sn-1 position and an acyl ester linkage at the sn-2 position of the glycerol backbone. Little is known about the specific functions of ether phospholipids. The only representative for which biological roles have clearly been established is 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine, better known by its trivial name, platelet activating factor (1). Other possible functions of ether phospholipids may include the protection of cells against certain types of oxidative stress by plasmalogens (2, 3).
The biosynthesis of ether phospholipids requires the concerted action of two enzymes and starts with the acylation of dihydroxyacetonephosphate (DHAP)1 by the enzyme DHAP acyltransferase (EC 2.3.1.42). The ether linkage is then introduced by a second enzyme, alkyl-DHAP synthase (EC 2.5.1.26), that catalyzes the exchange of the acyl chain in acyl-DHAP for a long chain fatty alcohol. Both enzymes are mainly, if not exclusively, located in peroxisomes (4).
The importance of peroxisomes for human physiology was emphasized by
the discovery of inherited diseases in humans caused by the loss of one
or more peroxisomal functions (5). The prototypic Zellweger syndrome is
a severe disorder characterized by a general loss of peroxisomal
functioning, including impaired ether lipid synthesis, defective
peroxisomal -oxidation, and defective phytanic acid oxidation. A
disorder with only a limited loss of peroxisomal functions is
rhizomelic chondrodysplasia punctata, in which phytanic acid oxidase,
DHAP acyltransferase, and alkyl-DHAP synthase are impaired.
Furthermore, in this disorder the peroxisomal 3-oxoacyl-CoA thiolase is
present as a 44-kDa precursor rather than as the 41-kDa mature enzyme
(6).
The deficiency of ether phospholipids in a number of peroxisomal disorders has clearly emphasized the indispensable role of peroxisomes for ether lipid synthesis in humans by indicating that this process cannot be taken over anywhere else in the cell. Studies on the peroxisomal enzymes required for glycero-ether bond formation have mainly been confined to experiments with crude subcellular or purified peroxisomal fractions. Although these studies have yielded highly relevant and valuable information on the intraperoxisomal localization and enzymological properties of the enzymes, including their mechanism of action (for recent review, see Ref. 7), they have provided little information on their structure. DHAP acyltransferase has only recently been purified to near homogeneity from guinea pig liver (8) and from human placenta (9), and enzymatic activity for guinea pig liver and human placenta was shown to reside in proteins of 69 and 65 kDa, respectively. Partial purifications of alkyl-DHAP synthase from Ehrlich ascites cells (10) and from guinea pig liver (11) have been described, but no information on molecular weight was reported. Recently, we succeeded in the purification of alkyl-DHAP synthase from guinea pig liver to homogeneity and provided evidence that the enzyme consisted of a single polypeptide chain with a molecular mass of 65 kDa (12). Both N-terminal and internal amino acid sequences have now been obtained from this protein, and we here report on the cloning and expression of the cDNA sequence coding for alkyl-DHAP synthase. The deduced amino acid sequence indicates that the mature enzyme is preceded by a 58-amino acid N-terminal extension containing a targeting signal to direct the protein to peroxisomes.
Materials
ProBlott was from Applied Biosystems, Foster City, CA. Cyanogen
bromide was from Aldrich. Triton X-100 was from Serva, Heidelberg, Germany. Moloney murine leukemia virus reverse transcriptase was bought
from New England Biolabs. Taq DNA polymerase and pGEM-T vector systems were from Promega, Madison, WI. Oligonucleotides were
manufactured by Isogen, Maarssen, The Netherlands. Terminal deoxynucleotidyltransferase was obtained from Appligene, Illkirch, France. RNAguard, T7 sequencing kit, and dNTPs were from Pharmacia Biotech. Isopropyl--D-thiogalactopyranoside (IPTG) was a
product from Research Organics Inc., Cleveland, OH. Pfu DNA
polymerase was from Stratagene, La Jolla, CA, and pET-15b vector was
from Novagen, Madison, WI.
Methods
Enzyme PurificationPurification of alkyl-DHAP synthase from guinea pig liver was done as described before, with some changes (12). Rather than with a Triton X-100 gradient from 0.075 to 0.4% (w/v) in buffer C (50 mM Tris-HCl (pH 7.4), 20% (v/v) ethylene glycol, 0.5 M NaCl, 1 mM MgCl2, 1 mM CaCl2, 1 mM dithiothreitol), the protein was eluted batchwise with 0.4% (w/v) Triton X-100 in buffer C from the concanavalin A column. Peak fractions were concentrated via a trichloroacetic acid precipitation followed by an acetone/ammonia precipitation. When protein was isolated for cyanogen bromide cleavage, a final purification step with the Bio-Rad PrepCell was used to obtain completely pure alkyl-DHAP synthase.
Cyanogen Bromide CleavageCyanogen bromide cleavage was based on the methods described by Gross (13). Briefly, alkyl-DHAP synthase (30 µg) was treated in 100 µl of 70% aqueous formic acid with 10 mg/ml cyanogen bromide at room temperature in the dark under nitrogen. After 24 h, 0.5 ml of H2O was added and the material was lyophilized. This was repeated once for total removal of cyanogen bromide.
Electrophoresis and Amino Acid SequencingSamples (10 µg of alkyl-DHAP synthase in case of N-terminal analysis, 30 µg of alkyl-DHAP synthase in case of internal analysis) were separated electrophoretically on a 10% T/4% C tricine SDS polyacrylamide gel as described by Schägger and von Jagow (14). The proteins or peptides were transferred to a sheet of ProBlott by semidry blotting and stained with Coomassie Brilliant Blue. The amino acid sequence analysis was performed by Sequence Center Utrecht using an Applied Biosystem protein sequencer (model 476A).
Reverse Transcription PCRTotal RNA was isolated from
1.5 g of guinea pig liver using a LiCl/urea method (15).
Poly(A)+ RNA was isolated with the Oligotex-dT kit (Qiagen)
according to the manufacturer's instructions. The reverse
transcriptase reaction (total volume, 30 µl) contained approximately
5 µg of heat-denatured (5 min at 95 °C) mRNA, 75 units of
Moloney murine leukemia virus reverse transcriptase, 1 mM
of each dNTP, 40 units of RNAguard, 50 mM Tris-HCl (pH
8.3), 8 mM MgCl2, 30 mM KCl, 10 mM dithiothreitol, 4 µM dT-17 primer, or 17 µg/ml random hexamers. The dT-17 primer contained a SalI
site at the 5 end (GAC
TTTTTTTTTTTTTTTTT). The
reaction was first incubated for 10 min at 23 °C and then for 60 min
at 37 °C in the case of the hexamer primed reaction and just 60 min
at 37 °C in the case of the dT-17 primed reaction. PCR was performed
in a volume of 50 µl with sense primer 1 against amino acids 8-16 of
the N-terminal sequence (GCIGCIACIGCIGCICCIAC(A/C/G/T)GC(A/C/G/T)AC) and antisense primer 2 against amino acids 2-7 of fragment I/VII (compare Fig. 1)
(CC(A/G)AA(T/C)TG(A/G)AA(T/C)TG(T/C)TG(A/G)TT), both at a
concentration of 1 µM, 200 µM of each dNTP,
2 units of Taq DNA polymerase, 10 mM Tris-HCl
(pH 9 at 25 °C), 50 mM KCl, 0.1% Triton X-100, and 1.5 mM MgCl2. The PCR temperature profile consisted
of 2 min at 95 °C and 35 cycles of 45 s at 95 °C, 30 s
at 57 °C, 3 min at 72 °C, and, finally, 7 min at 72 °C. An
8-µl aliquot was analyzed on an ethidium bromide-stained 1% agarose gel. PCR fragments were cloned into a pGEM-T vector using standard techniques (16). Nucleotide sequences were determined with a T7
sequencing kit using deaza-G/A mixes to minimize the risk of sequence
errors. Several independent clones were analyzed to guard against
errors made by Taq DNA polymerase. Both strands were
sequenced.
Amplification of cDNA Ends
The 3 end of the alkyl-DHAP
synthase cDNA was obtained by PCR using sense primer 3, corresponding to nucleotides 1072-1092 (compare Fig. 2)
and a dT-17 primer containing a SalI site. dT-17 primed
first-strand cDNA was used as a template. The temperature profile
was essentially the same as above. Reactions were analyzed on ethidium
bromide-stained agarose gels and with Southern blot techniques (16).
Products were cloned into the pGEM-T vector.
To obtain the 5 end of the cDNA sequence, hexamer-primed cDNA
was tailed with dATP using terminal deoxynucleotidyltransferase. Excess
hexamers and dNTPs from the reverse transcriptase reaction were removed
using Microcon-30 microconcentrators (Amicon). The recovered cDNA
was then tailed in a total volume of 10 µl containing 140 mM K-cacodylate, pH 7.2, 1 mM
CoCl2, 1 mg/ml bovine serum albumin, 0.33 mM
ZnSO4, 0.25 mM dATP, and 15 units of terminal deoxynucleotidyltransferase. The reaction was incubated at 37 °C for
10 min and at 65 °C for 15 min. PCR was performed on this preparation using antisense primer 4, corresponding to nucleotides 283-303, and the dT-17 primer for hybridization with the introduced dA
tail. PCR products were cloned and sequenced as described above. Because this method failed to obtain clones long enough to include the
start codon, the procedure was repeated with an antisense primer
corresponding to nucleotides 106-123.
The 1100-bp fragment obtained by PCR
was labeled with 40 µCi of 32P-dCTP using a decaprime DNA
labeling kit from Ambion according to the manufacturer's instructions.
An aliquot of 20 µg total RNA was separated on a 0.6% (w/v)
agarose/formaldehyde gel and transferred to a nylon sheet by capillary
blotting. Blots were baked at 80 °C for 2 h and prehybridyzed
at 42 °C in 1 M NaCl, 50% formamide, 10% dextrane
sulfate, 0.5% SDS, and 100 µg/ml herring sperm DNA. Hybridization
was performed with the 32P-labeled probe overnight. The
nylon sheet was washed twice with 2 × SSC, 0.1% SDS at room
temperature for 20 min and for 10 min with 0.2 × SSC, 0.5% SDS
at 55 °C. Autoradiograms were obtained by exposing the blot to x-ray
film with an intensifier screen at 80 °C for 1 week.
Guinea pig liver alkyl-DHAP synthase cDNA was obtained
by PCR with sense primer ATTCCCGCGGCACCGGAGTCTG
(nucleotides 223-241) containing an XhoI site (underlined)
and antisense primer TTACCATTGTTGAAGTCT (nucleotides 2020-2037) using
guinea pig liver cDNA as a template. To minimize the risk of
introducing errors, Pfu DNA polymerase (Stratagene) was
used. The PCR fragment was cloned after digestion with XhoI
into a pET-15b vector digested with BamHI (filled in) and
XhoI. The construct was transformed in E. coli
strain BL21(DE3). A 100-ml culture was grown overnight in Luria-Bertani
medium containing 50 µg/ml ampicillin and used to inoculate 1 liter
of Luria-Bertani medium containing 50 µg/ml ampicillin. When the OD
had reached 0.5, the culture was induced with 0.5 mM IPTG
and grown for an additional 3 hours. Cells were harvested by
centrifugation at 5000 rpm for 10 min in a Sorvall RC-2B centrifuge and
resuspended in 50 ml of ice-cold 50 mM Tris, pH 8.0, 40 mM EDTA, 0.25 M sucrose, and 0.2 mg/ml
lysozyme. After 30 min, an osmotic shock was given by addition of 50 ml
of 50 mM Tris, pH 8.0, and 40 mM EDTA. After 30 min, the cell suspension was sonicated three times for 90 s.
Thereafter, 1.9 ml of 10% Triton X-100 was added and the suspension
was again sonicated for 2 min. The inclusion bodies were pelleted by
centrifugation at 4000 rpm in a Beckman J6-HC centrifuge and, after
being washed, resuspended in 40 ml 10 mM Tris, pH 7.4, 2 mM EDTA. Before analysis, the supernatant was centrifuged
for 10 min at 22000 × g to remove all insoluble
material.
SDS-polyacrylamide gel electrophoresis was done as described by Laemmli (17). The alkyl-DHAP synthase activity assay was performed as described previously (12). Protein was determined according to Bradford (18) with bovine serum albumin as the standard.
Purified alkyl-DHAP synthase was subjected to SDS-polyacrylamide gel electrophoresis and blotted as described under "Methods" to separate the enzyme from trace impurities. After staining of the blot, the 65-kDa protein band was cut out and subjected to amino acid sequence analysis. The N-terminal amino acid sequence of alkyl-DHAP synthase, as deduced from three independent determinations, was found to be Lys-Ala-Arg-Arg-Ala-Ala-Ser-Ala-Ala-Thr-Ala-Ala-Pro-Thr-Ala-Thr-Pro-Ala-Ala-Pro-Glu-Ser-Gly-Ile-Ile.
In order to get additional information about the amino acid sequence of guinea pig liver alkyl-DHAP synthase, peptides were prepared by cyanogen bromide treatment of the enzyme. The cyanogen bromide treatment resulted in the complete disappearance of the mature enzyme and yielded several fragments upon tricine SDS-polyacrylamide gel electrophoresis (Fig. 1). Only the determinations that yielded unequivocal sequences are depicted. Because fragment I and VII turned out to be identical, we conclude that the cyanogen bromide cleavage was not complete at all methionines.
PCR-based Cloning of cDNAPCR performed with sense primer 1 and antisense primer 2 as described under "Experimental Procedures" yielded a 1100-base pair fragment on an ethidium bromide-stained agarose gel (results not shown). Sequencing confirmed that this band was indeed a fragment of alkyl-DHAP synthase cDNA, because this DNA fragment also coded for amino acids 16-25 of the N terminus. Furthermore, the derived amino acid sequence also included the sequence of cyanogen bromide fragment VI.
The PCR reaction products described under "Experimental Procedures"
to obtain the 3 end of the cDNA were analyzed with a Southern blot
using a 32P-labeled DNA probe corresponding to the region
between antisense primer 2 and sense primer 3 (data not shown).
Discrete bands were observed at 500 and 1000 bp and some faint bands at
1800 and 2200 bp. Two clones of the 1000-bp fragment were obtained in
the pGEM-T vector. The derived amino acid sequence of these clones
included the sequence of cyanogen bromide fragment III and an in-frame stop codon. No canonical polyadenylation signal (AATAAA) was found. Therefore, we assume that the dT-17 primer was able to anneal internally to an A-rich sequence, rather than to the poly(A) tail.
To further validate the obtained sequence, a PCR reaction was performed with primer 3 and an antisense primer corresponding to nucleotides 2020-2037 using hexamer-primed cDNA as a template. A single band with a length of about 1000 bp was obtained; it was cloned and sequenced. The obtained clones completely confirmed the previously determined sequence.
In order to obtain the sequence information about the 5 end of the
cDNA, the PCR reaction products were analyzed by Southern blotting
using a 32P-labeled synthase-specific probe (corresponding
to the region between primers 1 and 4). A smear was observed ranging
from 100 to about 400 nucleotides. These PCR products were cloned into the pGEM-T vector. The clones obtained this way were heterogeneous in
size and contained DNA sequences completely consistent with the
N-terminal amino acid sequence but did not yet contain a potential start codon. Therefore, the procedure was repeated using a primer upstream of primer 4 (see "Methods"). This yielded clones with an
in frame ATG. This ATG represents almost certainly the start codon,
because the surrounding sequence fits the Kozak sequence (19) very
nicely and there is an in frame TAG stop codon (nucleotides
12 to
10) upstream of this ATG.
Fig. 2 represents the composite sequence of the cDNA corresponding to guinea pig alkyl-DHAP synthase and the predicted sequence of the protein. The N-terminal sequence is included, as well as the sequences derived from cyanogen bromide cleavage fragments. The latter are, as expected, preceded by methionines. A presequence 58 amino acids long, which is not present in the mature enzyme, is found on the cDNA level. The predicted size of the mature enzyme (600 amino acids with a calculated molecular mass of 67.0 kDa) is in good agreement with the size observed by SDS-polyacrylamide gel electrophoresis (65 kDa). A FastA homology search2 revealed an unexpected 24.9% identity with Saccharomyces cerevisiae D-lactate dehydrogenase (cytochrome C) precursor (EC.1.1.2.4) (20) in a 293-amino acid overlap. In particular, alkyl-DHAP synthase amino acids 366-380 are completely identical with D-lactate dehydrogenase amino acids 309-323. The significance of this homology is presently not clear.
A hydrophobicity plot of the mature enzyme according to Kyte and
Doolittle (21) gave no clear evidence for the presence of a hydrophobic
membrane-spanning domain (data not shown). We previously reported (12)
that efficient solubilization of alkyl-DHAP synthase from membranes
prepared from peroxisome-enriched subcellular fractions required the
presence of detergent. To that end, we used Triton X-100. Similarly,
Brown and Snyder (22) solubilized the enzyme from Ehrlich ascites cell
particulate fractions with Triton X-100, whereas Horie et
al. (11) used CHAPS to solubilize the enzyme from guinea pig liver
peroxisomes. However, the requirement of detergents for solubilization
of membrane associated proteins is not restricted to integral membrane
proteins with hydrophobic transmembrane segments. This has recently
been exemplified by studies on prostaglandin H2 synthase 1. This enzyme was classified as an integral membrane protein because
detergents were required to extract the enzyme from the membrane (23).
Subsequently, the cDNA-deduced amino acid sequence predicted the
absence of transmembrane segments (24). However, the elucidation of the x-ray structure of the enzyme indicated an association with only one
monolayer of the membrane bilayer through the hydrophobic surface of
amphipatic -helices (25). Obviously, the lack of a transmembrane
segment and the exact integration of alkyl-DHAP synthase with the
peroxisomal membrane remains to be determined by independent
techniques.
Two targeting signals for peroxisomal proteins have been identified in
recent years. Peroxisomal targeting signal 1 consists of a C-terminal
tripeptide with the consensus sequence SKL (26, 27, 28). This signal is
used exclusively for matrix proteins and is not processed, as evidenced
by the fact that many matrix proteins can be detected by anti-SKL
antibodies. A cleavable peroxisomal targeting signal 2 (PTS2) has
initially been identified by Swinkels et al. (29) in the
N-terminal extension of rat 3-ketoacyl-thiolase, a rather rare example
of a peroxisomal protein that is not synthesized at its mature size but
with an N-terminal presequence. Similar PTS2 signals appeared to be
present in mature yeast thiolases (29). Fig. 3 shows
that the presequence of alkyl-DHAP synthase contains the peroxisomal
targeting signal 2 in the amino acid sequence at positions 37-45. In
particular, the homology with the PTS2 signal in mammalian
3-ketoacyl-thiolases is excellent. It is reasonable to assume that the
presence of this signal is responsible for directing alkyl-DHAP
synthase to peroxisomes. It is noteworthy that the presequence of
alkyl-DHAP synthase, with its 58 amino acids, is considerably longer
than the N-terminal extensions of either the A- or the B-type
precursors for rat thiolases, which consist of 36 and 26 amino acids,
respectively (29). The reason for this and the function of the extra
amino acids, which have a remarkable poly-alanine segment, is currently
unknown. It has recently been reported, however, that the N terminus of PTS2 carrying proteins can be extended by a large number of additional residues and still be recognized by Pas7p, the import receptor for PTS2
proteins in S. cerevisiae (30).
Apart from the PTS2 signal, alkyl-DHAP synthase and mammalian thiolases contain additional sequence homology in their presequences, including a cysteine at the cleavage site (Fig. 3). Thus, both proteins may well be processed by the same peroxisomal protease. In this respect, it is interesting to note that in the peroxisomal disorder rhizomelic chondrodysplasia punctata, the peroxisomal thiolase is neither imported nor processed (6). It is conceivable that this may also be the case for alkyl-DHAP synthase and that these phenomena underlie the previously reported deficiency of alkyl-DHAP synthase enzymatic activity in rhizomelic chondrodysplasia punctata (31). The experimental addressing of these possibilities will have to await the development of specific antibodies.
Alkyl-DHAP Synthase mRNA and Expression of the Enzyme in E. coliNorthern blot analysis (Fig. 4) revealed one
major band with an estimated size of about 4200 nucleotides. Two
additional faint bands with a higher molecular weight were detected as
well. Because these bands could not be removed by further, more
stringent washing, we assume that these represent alkyl-DHAP synthase
mRNAs that are not fully processed.
Induction of pET-15b-alkyl-DHAP synthase-transformed E. coli
strain BL21(DE3) with IPTG resulted in the expression of a 65-kDa protein and, to a much lesser extent, of an approximately 55-kDa protein (Fig. 5). The latter most likely consists of a
degradation product of the 65-kDa protein. Both proteins were found to
be highly enriched in inclusion bodies, although the 65-kDa protein was
partially recovered in the supernatant as well (Fig. 5, lane 6). The specific activities of alkyl-DHAP synthase were measured in homogenates, inclusion bodies, and supernatant and expressed as
milliunits/mg protein. As expected, the homogenate of control cells
that had been transformed with an empty vector showed no detectable
synthase activity. High enzymatic activities of 3.1 and 2.3 milliunits/mg were found in homogenates and supernatants, respectively,
of IPTG-induced cells transformed with a vector carrying the synthase
insert. For comparison, the specific activity of a guinea pig liver
homogenate under these conditions amounts to 0.03 milliunits/mg protein
(12). The specific synthase activity of 0.06 milliunits/mg in inclusion
bodies suggests that the enzyme is not easily accessible for substrate
in these precipitates or that it is present in a less active form. The
latter may hold for the expressed enzyme in general. When the amount of
the 65-kDa protein in homogenate and supernatant was estimated by
visual inspection of staining intensities against known amounts of
bovine serum albumin, the soluble alkyl-DHAP synthase was estimated to have a specific activity amounting to about 15% of that previously determined for the enzyme purified from guinea pig liver (12). This
lower value may be caused by the presence of the His-tag in the
expressed enzyme or may result from less efficient folding in E. coli. Nevertheless, the fact that the expressed enzyme is active
provides independent proof that we cloned the cDNA for alkyl-DHAP
synthase.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) Y08826[GenBank].
We thank Annie Timmermans-Hereijgers for the aid with the expression and Jan Biermann for the performance of the activity assay.